
Medicross Pharma-Chem Limited
About Medicross Pharma-Chem Limited
Data last updated:
Medicross Pharma-Chem Limited is a public limited company based in Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 30 September 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1996PLC082346. Its GSTIN is 09AAACM9391B1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹16 Lakh. It is led by directors including Anu Dewan (Whole-Time Director) and Tariq Masood (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 60 Azad Apartments Plot No. 111 I.P. Extension, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.48 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹5.1 Lakh (net margin 0.7%) and EBITDA of ₹11.66 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹2 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medicross Pharma-Chem Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 60 Azad Apartments Plot No. 111 I.P. Extension, Delhi, India – 110092
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Medicross Pharma-Chem Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medicross Pharma-Chem is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medicross Pharma-Chem Limited, buy the company report.
Financials of Medicross Pharma-Chem Limited
FY 2025 filings availableMedicross Pharma-Chem Limited reported revenue of ₹7.48 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 6% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medicross Pharma-Chem Limited, buy the company report.
Board of directors of Medicross Pharma-Chem Limited
Medicross Pharma-Chem has 6 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anu Dewan | Whole-Time Director | 26 Mar 2015 | 11 Years 7 Months | Current |
| Tariq Masood | Whole-Time Director | 26 Mar 2015 | 11 Years 7 Months | Current |
| Anirudh Bhardwaj | Director | 15 Mar 2017 | 9 Years 8 Months | Current |
| Sakshi Bhardwaj | Director | 15 Mar 2017 | 9 Years 8 Months | Current |
| Prateek Dewan | Whole-Time Director | 01 Jan 2023 | 3 Years 10 Months | Current |
| Arif Masood | Whole-Time Director | 30 Sep 1996 | 30 Years 1 Months | Current |
Peer comparison
Medicross Pharma-Chem Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trio Biotech Private Limited | ₹7.52 Cr (FY 2025) | 37.0% | Bokaro, Jharkhand, India | |||
| Shakambhari Medical Private Limited | ₹7.52 Cr (FY 2025) | 87.0% | Lucknow, Uttar Pradesh, India | |||
| Hsa Pharma Private Limited | ₹7.52 Cr (FY 2025) | -12.0% | Chennai, Tamil Nadu, India | |||
| Medicross Pharma-Chem Limitedthis company | ₹7.48 Cr (FY 2025) | ₹5.1 Lakh | 0.7% | 6.0% | Delhi, India | |
| Oshian Lifecare Private Limited | ₹7.48 Cr (FY 2025) | -6.0% | Delhi, India | |||
| M3 Healthcare Private Limited | ₹7.47 Cr (FY 2024) | 8.0% | Bangalore, Karnataka, India | |||
| Ishjas Pharma Private Limited | ₹7.47 Cr (FY 2024) | -36.0% | Delhi, India | |||
| Dr.Goyal Medical Private Limited | ₹7.46 Cr (FY 2024) | 6.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Medicross Pharma-Chem Limited, buy the company report.
Auditor
Medicross Pharma-Chem Limited is audited by GUPTA MANGLIK & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA MANGLIK & CO. | FY 2023 | 072697 |
Shareholding
The shareholding of Medicross Pharma-Chem Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medicross Pharma-Chem Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 1991 | 90056261 | Canara Bank | ₹2 Lakh | Open |
To see the full charge records of Medicross Pharma-Chem Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Medicross Pharma-Chem Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Modi-Mundipharma Pvt. Limited | Disposed |
To see the full case history of Medicross Pharma-Chem Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicross Pharma-Chem Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medicross Pharma-Chem has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACM9391B1ZE | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medicross Pharma-Chem Limited, buy the company report.
Recent activity
Medicross Pharma-Chem Limited has 14 board changes on record since 1996: 6 appointments and 8 cessations. The latest: Anu Dewan ceased to be Director on 23 Feb 2023.
7 earlier events are in the company report.
Frequently asked questions
Medicross Pharma-Chem is an active public limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 30 September 1996 (30+ years old) and is registered under CIN U24231DL1996PLC082346.
Medicross Pharma-Chem has 6 current directors:
- Anu Dewan - Whole-Time Director
- Tariq Masood - Whole-Time Director
- Prateek Dewan - Whole-Time Director
- Arif Masood - Whole-Time Director
- Anirudh Bhardwaj - Director
- Sakshi Bhardwaj - Director
The latest financial statements of Medicross Pharma-Chem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medicross Pharma-Chem is 09AAACM9391B1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medicross Pharma-Chem is U24231DL1996PLC082346. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicross Pharma-Chem has 1 court case on record: 1 filed against it.
Medicross Pharma-Chem was incorporated on 30 September 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medicross Pharma-Chem by revenue are Trio Biotech Private Limited, Shakambhari Medical Private Limited, Hsa Pharma Private Limited, Oshian Lifecare Private Limited, M3 Healthcare Private Limited and 2 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anu Dewan ceased to be Director on 23 Feb 2023. Prateek Dewan was appointed as Whole-Time Director on 01 Jan 2023. Sakshi Bhardwaj ceased to be Additional Director on 01 Oct 2017. Medicross Pharma-Chem has 14 board changes on record in total.
The registered office of Medicross Pharma-Chem is at F – 60 Azad Apartments Plot No. 111 I.P. Extension, Delhi, India – 110092.
Medicross Pharma-Chem operates in the healthcare industry, in the medical equipment retail and distribution segment.

